Home Health

Home Home Health

Categories of Products

Company Profile

Home Health

KataNase™ An effective bio-disinfectant which neutralizes 99.9% of known viruses and can be applied on solid surfaces, including fabrics, promoting hygiene and safety.

KataNase™

Beyond the Clean You See: Surface Disinfectant Limitations

The need for effective disinfectants has never been more apparent in the post-pandemic world. While the disinfectant market continues to expand rapidly, with projections reaching USD 15.3 billion by 2032, a significant gap exists in products tailored specifically for a broad spectrum of solid surfaces, including fabrics. Common disinfectants might not provide optimal protection on varied surfaces or could damage sensitive materials.

Growing Demand: With the global antiseptic and disinfectant market valued at USD 29.15 billion in 2022, the demand is undeniable.
Specialized Need: Not all disinfectants are designed for diverse surface applications, leaving consumers underserved.
Material Concern: Some surfaces, especially fabrics, risk damage or reduced efficacy with generic disinfectants.

Revitalizing Europe’s Olive Groves with XylePhage™

Developed by Auxergen, XylePhage™ is a scientifically engineered biocontrol agent targeting the destructive Xf bacteria in the tree’s xylem – the vital water and nutrient transport channel. Through its targeted action, it effectively eliminates the bacteria, thus preventing the blockage of nutrients and curbing the progression of the disease that has been devastating olive groves.

XylePhage™ offers several substantial benefits

Environmental Safety: Green alternative to chemical pesticides, reducing potential environmental harm.
Xf Specificity: It is formulated to target and eliminate the Xf bacteria exclusively, thereby not affecting other organisms in the ecosystem.
Effective Treatment: Works proficiently on symptomatic and asymptomatic trees, making it a widespread solution.
Easy Application: Simplifies the treatment process with its design that allows direct application to the tree’s xylem, making it easier to reach the bacteria.
Cost Savings for Farmers: A one-time application that translates to notable financial savings for farmers in the long term.

Currently, Auxergen is conducting nursery trials with XylePhage™. The anticipated milestones are:

Filing for EU regulatory approval in 2024.
Projected availability to farmers by 2026.

Capitalizing on Olive Demand: A Solution for a Shrinking Resource

Auxergen is seeking investments to bring XylePhage™ to market, leveraging :

A strong team of scientists and engineers with a history of developing and commercializing biocontrol agents.
Established relationships with critical stakeholders in the scientific community and the olive oil industry.

Auxergen projects potential revenue as follows :

Estimated revenue generation of $293 million annually.
Initiating negotiations with individual EU countries for a share of the $5.8B annual loss.

33% Income Tax Credit

As a Qualified Maryland Biotechnology Company (QMBC), investors have access to the Maryland Biotechnology Investment Incentive Tax Credit (BIITC). QMBC status enables investors to receive a 33% income tax credit on eligible investments, up to $250,000 per investor.

An investment of $750,000 in Auxergen can yield a $250,000 tax credit from the State of Maryland. This opportunity is open to investors globally, as long as they are from a jurisdiction with a US-correspondent tax system.

The company is aiming to raise $11 million, capital designated to facilitate the commercialization of our XylePhage product. This promising product is positioned as a solution to the Olive Quick Decline Syndrome (OQDS), which is presently undermining European olive oil production on a large scale.

XanthaPhage

Citrus and Rice Under Siege: Climbing Costs and Dwindling Yields in Key Agricultural Sectors

Agriculture’s critical sectors face tangible threats. Citrus trees, vital for Florida’s economy, suffer from citrus canker, reducing marketable produce and raising production costs. Rice, a staple food for billions globally, confronts bacterial blight, which can obliterate up to 75% of crops in severe conditions. As climate change looms, the threats intensify, potentially costing the US rice market an additional $112 million annually. The results? Unstable yields, disrupted markets, and elevated consumer prices.

Declining Yields: Citrus canker and rice bacterial blight drastically cut marketable produce.
Economic Ripple: Elevated production costs in the citrus sector and potential $112 million yearly loss in the US rice market.
Consumer Impact: Diminished rice quality and quantity, leading to higher market prices.

Revolutionizing Crop Health: Direct Combat Against Citrus Canker and Rice Blight

XanthaPhage™ offers an innovative agricultural solution designed to counteract the damaging effects of citrus canker and rice blight. This product aims to enhance crop health through targeted treatment, resulting in increased yields. By revitalizing these essential agricultural sectors, XanthaPhage™ not only ensures food security but also aids in stabilizing market prices and reducing production costs for farmers.

Capitalizing on Agricultural Innovation: XanthaPhage™ Licensing Opportunity

Licensing XanthaPhage’s technology provides a gateway to two high-value agricultural sectors: citrus and rice. With a scalable solution that addresses pressing disease challenges, investors can capitalize on a pivotal role in safeguarding global food supply. XanthaPhage ensures access to a continually growing market, positioning for substantial returns and long-growth from the ongoing demand for effective agricultural solutions.

MarlePhage™

Urban Gardens at Risk: Tackling the Hidden Hazard of Soil Contamination

Urban and suburban gardens are increasingly plagued by heavy metal contamination and toxic organic compounds. This soil pollution jeopardizes the safety of homegrown produce and poses risks to local ecosystems and residents’ health. The consequences of this contamination are diverse and pressing:

Economic Concerns: Soil contamination accounts for global economic losses, with heavy metal issues alone surpassing US $10 billion annually.
Residential Health: Toxins from homegrown crops enter households, increasing health risks for families.
Local Ecosystem Impact: Native plants and small wildlife suffer in these tainted garden environments, leading to reduced biodiversity.
Home Gardening Setback: Contaminated soil deters homeowners from gardening, impacting the quality and yield of their produce.

MarlePhage™: Turning Polluted Soils into Safe, Productive Grounds

MarlePhage™ is a cutting-edge soil reclamation technology. It dissolves those dangerous organic compounds and adeptly sequesters heavy metals, transforming once-polluted soils back to safe and productive grounds.

Capitalizing on Consumer Sales & Licensing Opportunities

The need for effective soil reclamation technologies grows as urbanization and industrial activities surge. MarlePhage, as a consumer-focused soil reclamation technology, steps in to address this marketplace need.
Licensing Potential: Beyond direct consumer sales, there’s an opportunity to license the MarlePhage technology to garden product companies, creating an additional revenue stream.